Loading provider…
Loading provider…
Nephrology Physician in Dallas, TX
NPI: 1245209725Primary Practice Location
UT OF TEXAS SOUTHWESTERN UNIVERSITY HOSPITAL - WILLIAM P. CLEMENTS JR.
6201 Harry Hines Blvd, Dallas, TX
Primary Employer
University of Texas Southwestern Medical Center at Dallas
utswmed.org
HQ Phone
Get MD Robert's Phone Numberphone_androidMobile
Get MD Robert's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
CA State Medical License
1980
TX State Medical License
1983 - 2025
TN State Medical License
1997 - 1998
MI State Medical License
1978 - 1982

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Nephrology
Baylor College Of Medicine
bcm.edu
Residency • Internal Medicine
1979 - 1980
University of Illinois College of Medicine - Chicago
medicine.uic.edu
Medical School
Until 1977
University of Texas Southwestern Medical Center
Fellowship • Nephrology
1982 - 1983
University of Michigan
Residency • Internal Medicine
1977 - 1979
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 31 | 34 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 16 | 16 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 15 | 16 |
Authors: William Mitch
Journal: Kidney Int
Rationale and design of the Chronic Kidney Disease Antidepressant Sertraline Trial (CAST).
Authors: Benji Kurian, Nishank Jain, Madhukar Trivedi
Publication Date: 2012-07-05
Lead Sponsor: University of Texas Southwestern Medical Center
Intervention / Treatment: DRUG: SGLT2 inhibitor
Lead Sponsor: The University of Texas at Arlington
Collaborators: University of Texas, Southwestern Medical Center at Dallas
Intervention / Treatment: OTHER: Placebo, DRUG: Pioglitazone
Lead Sponsor: The University of Texas at Arlington
Intervention / Treatment: OTHER: Placebo, DRUG: L-Arginine